$126.61+0.02 (+0.02%)
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
Integer Holdings Corporation in the Healthcare sector is trading at $126.61 with a market capitalization of $4.3B. Wall Street consensus targets $121.80 (5 analysts), implying a -3.8% move over the next 12 months. The stock is currently near its 52-week high of $126.80, remaining 29.1% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $464.11Mβ | $439.58Mβ | $472.06Mβ | $467.69Mβ | $476.49M |
| Gross Profit | $112.94Mβ | $109.59Mβ | $124.76Mβ | $126.16Mβ | $129.15M |
| Operating Income | $44.61Mβ | $35.47Mβ | $54.55Mβ | $65.90Mβ | $62.90M |
| Net Income | $23.61Mβ | $16.51Mβ | $48.61Mβ | $39.68Mβ | $37.01M |
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structura...